Govt to allow sale of these Medicines with out Prescription

Neither the Drugs and Cosmetics Act, 1940 nor the Drugs & Cosmetics Rules, 1945 (D&C) defines OTC medicines.

2116
Govt of India

Last Updated on January 21, 2022 by The Health Master

As part of a new over-the-counter (OTC) policy for drugs, India will soon allow the sale of certain drugs without the requirement of a prescription.

A senior government official said the Drugs Technical Advisory Board (DTAB), the government’s top advisory body on drugs, has approved the new policy and a draft notification will soon be issued by the health ministry.

The DTAB has approved a list of OTC drugs that includes medicines like:

  • Antifungal infections,
  • Analgesics (pain killers),
  • Cough syrups,
  • Decongestants,
  • Laxatives, 
  • Antiseptics, 
  • Medicines for gum infections.

“The aim is to reduce treatment costs and also promote self-care without compromising safety, ” added the official.

Unlike other countries like the US, UK, or China, India does not have a policy framework to support and regulate the distribution, marketing, and consumption of OTC drugs.

This is despite the fact that commonly used medicines for coughs and colds, as well as contraceptives, are sold over the counter.

Neither the Drugs and Cosmetics Act, 1940 nor the Drugs and Cosmetics Rules, 1945 (D&C) defines OTC medicines.

Officials told that the list of over-the-counter drugs has been shortlisted, based on evidence of their safety, availability, and non-habit forming nature.

Once the final notification comes into effect, pharmacists will be able to dispense drugs for minor conditions without a doctor’s prescription.

DCGI needs more safety data for Covaxin nod for under 12

USFDA approves add-on therapy to lower Cholesterol

Capsule introduced that can inhibit viral replication

Drug alert: 33 out of 1385 samples declared as NSQ in December 2021

Govt issues revised guidelines on use of drugs in Covid patients

USFDA gives approval to Strides Pharma for generic Tamiflu

DCGI gives nod to for Phase 3 Clinical Trial on drug…

Pharmaceutical Budget 2022: Expectations

NPPA to conduct study on Price Regulatory Policies in these 10…

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner